NeuroPace Past Earnings Performance
Past criteria checks 0/6
NeuroPace's earnings have been declining at an average annual rate of -6.8%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 17.6% per year.
Key information
-6.8%
Earnings growth rate
99.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 17.6% |
| Return on equity | -302.4% |
| Net Margin | -41.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Revenue & Expenses Breakdown
How NeuroPace makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 72 | -30 | 56 | 22 |
| 31 Mar 24 | 69 | -32 | 56 | 21 |
| 31 Dec 23 | 65 | -33 | 55 | 21 |
| 30 Sep 23 | 60 | -38 | 55 | 20 |
| 30 Jun 23 | 55 | -42 | 54 | 21 |
| 31 Mar 23 | 49 | -46 | 52 | 22 |
| 31 Dec 22 | 46 | -47 | 51 | 22 |
| 30 Sep 22 | 44 | -47 | 50 | 22 |
| 30 Jun 22 | 43 | -43 | 46 | 21 |
| 31 Mar 22 | 45 | -39 | 43 | 20 |
| 31 Dec 21 | 45 | -36 | 39 | 18 |
| 30 Sep 21 | 45 | -30 | 34 | 17 |
| 30 Jun 21 | 47 | -26 | 32 | 16 |
| 31 Mar 21 | 42 | -26 | 28 | 15 |
| 31 Dec 20 | 41 | -24 | 28 | 16 |
| 31 Dec 19 | 37 | -30 | 30 | 18 |
Quality Earnings: NPCE is currently unprofitable.
Growing Profit Margin: NPCE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NPCE is unprofitable, and losses have increased over the past 5 years at a rate of 6.8% per year.
Accelerating Growth: Unable to compare NPCE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NPCE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: NPCE has a negative Return on Equity (-302.44%), as it is currently unprofitable.